Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...
As Congress debates renewing the Act for ALS, it must prepare for the coming era of precision ALS medicine by prioritizing ...
The U.S. Senate has a plan to improve drug development for rare disease patients. The exit of controversial CBER chief Vinay Prasad will help clear the path.
Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at the final stages of development. Unlike traditional methods that rely on ...
A new drug, FLAV-27, targets epigenetic changes in Alzheimer’s. In preclinical studies, the drug reduced levels of ...
A surprising lab discovery reveals a light-powered way to tweak complex drugs faster, cleaner, and later in development.
Researchers developed FLAV-27, an epigenetic drug that inhibits G9a to restore gene expression in Alzheimer’s models. The treatment reduced amyloid and tau, improved cognition and synaptic function, ...
Understanding food safety risks throughout processing is the first step to establishing an effective sanitation program.
Amid rising debate within the medical community, the US FDA has spoken out to defend how it reviews and authorizes new ...
A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer's disease. Unlike ...
Lawyers’ pleas for extensions reveal post-DOGE staffing woes at federal agencies’ Freedom of Information Act offices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results